Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background information. TSEs (transmissible spongiform encephalopathies) are neurodegenerative disorders affecting humans and animals. PrP Sc, a conformationally altered isoform of the normal prion protein (PrP C), is thought to be the pathogenic agent. However, the biochemical composition of the prion agent is still matter of debate. The potential transmission risk of the prion agent through biological fluids has been shown, but the development of competitive diagnostic tests and treatment for TSEs requires a more comprehensive knowledge of the agent and the cellular mechanisms by which it is disseminated. With this aim, we initiated characterization of the prion agent and the pathways by which it can be propagated using the cellular model system neuroblastoma (N2a). Results. The present study shows that N2a cells infected with scrapie release the prion agent into the cell culture medium in association with exosome‐like structures and viral particles of endogenous origin. We found that both prion proteins and scrapie infectivity are mainly associated with exosome‐like structures that contain viral envelope glycoprotein and nucleic acids, such as RNAs. Conclusions. The dissemination of prions in N2a cell culture is mediated through the exosomal pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prions and their partners in crime
Caughey, B., & Baron, G. S. (2006) · Nature · doi:10.1038/nature05294 · Cited by 295 · cited 1×
“However, none of the reports provided conclusive evidence that the infectious agent was composed entirely of the malformed prion protein PrPSc (Caughey and Baron, 2006).”
Background
Cited by
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Gardiner, C., Sargent, I. L., Wood, M. J. A., & Cooper, J. M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.029 · Cited by 748
Subra, C., Grand, D., Laulagnier, K., Stella, A., Lambeau, G., Paillasse, M., De Medina, P., Monsarrat, B., Perret, B., Silvente-Poirot, S., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003657 · Cited by 633
Bellingham, S. A., Coleman, B. M., & Hill, A. F. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks832 · Cited by 440
Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
Thompson, A. G., Gray, E., Heman-Ackah, S. M., Mäger, I., Talbot, K., Andaloussi, S. E., Wood, M. J., & Turner, M. R. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.68 · Cited by 431
Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases?
Bellingham, S. A., Guo, B. B., Coleman, B. M., & Hill, A. F. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00124 · Cited by 412
Exosomes: The Future of Biomarkers in Medicine
Properzi, F., Logozzi, M., & Fais, S. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.63 · Cited by 391
Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics
Kalani, A., Tyagi, A., & Tyagi, N. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8544-1 · Cited by 332
Gangoda, L., Boukouris, S., Liem, M., Kalra, H., & Mathivanan, S. (2015) · PROTEOMICS · doi:10.1002/pmic.201400234 · Cited by 301
“In a similar study, neuroblastoma N2a cells were noted to release PrPs predominantly via EVs [91].”
BackgroundProtein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors
Shen, B., Wu, N., Yang, J.-M., & Gould, S. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208660 · Cited by 285
Are synucleinopathies prion-like disorders?
Angot, E., Steiner, J. A., Hansen, C., Li, J.-Y., & Brundin, P. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70213-1 · Cited by 251
The role of extracellular vesicles in neurodegenerative diseases
Quek, C., & Hill, A. F. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.090 · Cited by 213
“M AN US CR IP T AC CE PT ED 6 Exosomes are released into the extracellular space [32], and in the body fluids such as blood, milk, saliva, cerebrospinal fluid (CSF), and urine [33, 34].”
InfluentialColeman, B. M., & Hill, A. F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.007 · Cited by 208
Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
Vingtdeux, V., Sergeant, N., & Buée, L. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00229 · Cited by 116
“exosomes was the prion protein (PrP; Fevrier et al., 2004; Alais et al., 2008).”
BackgroundExtracellular Vesicles in Brain Tumors and Neurodegenerative Diseases
Ciregia, F., Urbani, A., & Palmisano, G. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00276 · Cited by 110
“Actually, prion agent seems to be released from the cell in association with exosomes contributing to spread neurodegeneration (Fevrier et al., 2004; Vella et al., 2007; Alais et al., 2008).”
BackgroundExosomes in neurologic and psychiatric disorders
Tsilioni, I., Panagiotidou, S., & Theoharides, T. C. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.05.005 · Cited by 93
Liu, S., Hossinger, A., Heumüller, S.-E., Hornberger, A., Buravlova, O., Konstantoulea, K., Müller, S. A., Paulsen, L., Rousseau, F., Schymkowitz, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25855-2 · Cited by 72
The regulation of exosome function in the CNS: implications for neurodegeneration
Properzi, F., Ferroni, E., Poleggi, A., & Vinci, R. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14204 · Cited by 62
Reactivated endogenous retroviruses promote protein aggregate spreading
Liu, S., Heumüller, S.-E., Hossinger, A., Müller, S. A., Buravlova, O., Lichtenthaler, S. F., Denner, P., & Vorberg, I. M. (2023) · Nature Communications · doi:10.1038/s41467-023-40632-z · Cited by 48
Muth, C., Schröck, K., Madore, C., Hartmann, K., Fanek, Z., Butovsky, O., Glatzel, M., & Krasemann, S. (2017) · Brain Pathology · doi:10.1111/bpa.12441 · Cited by 23
Metadata
- Authors
- Alais, S., Simoes, S., Baas, D., Lehmann, S., Raposo, G., Darlix, J. L., & Leblanc, P.
- Venue
- Biology of the Cell
- Publisher
- Wiley
- Published
- 2008-10
- Volume
- 100
- Issue
- 10
- Pages
- 603-618
- ISSN
- 0248-4900 (ISSN-L)
- 1768-322X
- OpenAlex
- W2017680929
- Cited by
- 140
- References
- 1
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.